title: Dendritic cells and dinitrochlorobenzene (DNCB): a new treatment approach to AIDS.
abstract: Recent studies suggest that antigen-presenting cells (dendritic cells) may play a key role in the pathogenesis of human immunodeficiency virus (HIV) infection. This observation makes new immunomodulatory treatment strategies desirable. Topical dinitrochlorobenzene (DNCB) is discussed as a possible treatment modality in the context of its proven therapeutic uses and its immunomodulatory effect on dendritic cells. DNCB may be a safe, inexpensive, and widely available treatment option for HIV disease.
authors.affiliation: Children's Hospital of San Francisco, CA 94118.
authors.forename: R B
authors.initials: RB
authors.lastname: Stricker
authors.forename: B F
authors.initials: BF
authors.lastname: Elswood
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000191:economics / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology*; D004137:Dinitrochlorobenzene / Q000627:therapeutic use*; D006678:HIV / Q000187:drug effects / Q000254:growth & development; D006801:Humans; D007801:Langerhans Cells / Q000276:immunology
chemical_list: D004137:Dinitrochlorobenzene